Contrast-induced nephropathy is an acute renal dysfunction that occurs within 1-3 days after the administration of a radiopaque drug, leading to an increase in serum creatinine by at least 26.5 µmol/l (25%) or more compared to baseline. Usually it is asymptomatic. In severe cases, it is manifested by oliguria, renal edema, weakness, drowsiness, loss of appetite, nausea.
The application was developed by the Innovation Center of the Tashkent Pediatric Medical Institute. IC TashPMI adheres to the highest scientific standards. Our CIN Risk application is used to diagnose the likelihood of a contrast-induced nephropathy origin, as evidenced by the temporal relationship of renal pathology with contrast radiography. The doctor, having noted the existing indicators in the patient, at the end of the test receives the probability of the risk of developing contrast-induced nephropathy with recommendations for further actions.
The CIN service is for healthcare professionals only.